Benefit of long-term treatment with teriflunomide on disability outcomes: results from TEMSO and TOWER

被引：0
|
作者：
Lublin, F. [1 ]
Freedman, M. S. [2 ,3 ]
Comi, G. [4 ]
Miller, A. E. [5 ]
Thangavelu, K. [6 ]
Truffinet, P. [7 ]
Kappos, L. [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Sanofi Genzyme, Cambridge, MA USA
[7] Sanofi Genzyme, Chilly Mazarin, France
[8] Univ Hosp Basel, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
基金：
新加坡国家研究基金会; 美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P691
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [1] Benefit of Long-term Treatment With Teriflunomide on Disability Outcomes: Results From TEMSO and TOWER
    Lublin, Fred
    Freedman, Mark S.
    Comi, Giancarlo
    Miller, Aaron E.
    Thangavelu, Karthinathan
    Truffinet, Philippe
    Kappos, Ludwig
    [J]. NEUROLOGY, 2017, 88
  • [2] Long-term Efficacy and Safety Outcomes of Teriflunomide Treatment in TEMSO and TOWER
    Oh, Jiwon
    Freedman, Mark S.
    Benamor, Myriam
    Poole, Elizabeth
    Chavin, Jeffrey
    Comi, Giancarlo
    [J]. NEUROLOGY, 2018, 90
  • [3] Long-term disability outcomes in teriflunomide-treated patients in TEMSO and TOWER: an EDSS and FSS categorical analysis
    Lublin, F.
    Miller, A.
    Truffinet, P.
    Thangavelu, K.
    Mandel, M.
    Freedman, M. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 903 - 903
  • [4] Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
    Sormani, Maria Pia
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Rufi, Pascal
    Simonson, Catherine
    De Stefano, Nicola
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (05):
  • [5] Long-term Disability Outcomes in Teriflunomide-Treated Patients in TEMSO and TOWER: An Analysis Utilizing the Topographical Model of MS
    Krieger, Stephen
    Freedman, Mark S.
    Miller, Aaron E.
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Mandel, Matt
    Lublin, Fred
    [J]. NEUROLOGY, 2018, 90
  • [6] Impact of Long-term Teriflunomide Treatment on Severe Relapses: Analysis of TEMSO and TOWER Extensions
    Maeurer, Mathias
    Miller, Aaron
    Comi, Giancarlo
    Kappos, Ludwig
    Wolinsky, Jerry
    Stange, Martin
    Macdonell, Richard
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Freedman, Mark
    [J]. NEUROLOGY, 2017, 88
  • [7] IMPACT OF LONG-TERM TERIFLUNOMIDE TREATMENT ON LYMPHOCYTE COUNTS AND INFECTIONS IN POOLED TEMSO AND TOWER STUDIES
    Comi, Giancarlo
    Macdonell, Richard
    Benamor, Myriam
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Mandel, Matt
    Freedman, Mark S.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E27 - E27
  • [8] Effect of teriflunomide on relapses associated with disability worsening: results from the TEMSO and TOWER studies
    O'Connor, P. W.
    Comi, G.
    Thangavelu, K.
    Truffinet, P.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 526 - 526
  • [9] Effect of Teriflunomide on Relapses Associated with Disability Worsening: Results from the TEMSO and TOWER Studies
    O'Connor, Paul
    Thangavelu, Karthinathan
    Truffinet, Philippe
    Comi, Giancarlo
    [J]. NEUROLOGY, 2016, 86
  • [10] TERIFLUNOMIDE EFFICACY AND SAFETY ANALYSES: RESULTS FROM TEMSO AND TOWER
    Freedman, Mark
    Confavreux, Christian
    Olsson, Tomas
    Comi, Giancarlo
    Miller, Aaron
    Wolinsky, Jerry
    Kappos, Ludwig
    Benzerdjeb, Hadj
    Dukovic, Deborah
    Truffinet, Philippe
    O'Connor, Paul
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1399 - 1400
12345